Transmissible spongiform encephalopathy

Jump to: navigation, search

Transmissible spongiform encephalopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transmissible spongiform encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Neurocognitive Disorder Due to Prion Disease

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transmissible spongiform encephalopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transmissible spongiform encephalopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transmissible spongiform encephalopathy

CDC on Transmissible spongiform encephalopathy

Transmissible spongiform encephalopathy in the news

Blogs on Transmissible spongiform encephalopathy

Directions to Hospitals Treating Transmissible spongiform encephalopathy

Risk calculators and risk factors for Transmissible spongiform encephalopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

For patient information, click here

Synonyms and Keywords: TSE; prion diseases

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Transmissible spongiform encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Major or Mild Neurocognitive Disorder Due to Prion Disease

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

References

  • This entry incorporates public domain text originally from the National Institute of Neurological Disorders and Stroke, National Institutes of Health [3] and the U.S. National Library of Medicine [4]
  • Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ (2000). "Iatrogenic Creutzfeldt-Jakob disease at the millennium". Neurology. 55 (8): 1075–81. PMID 11071481.
  • Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003). "Familial and sporadic fatal insomnia". Lancet Neurol. 2 (3): 167–76. PMID 12849238.
  • Prusiner SB (2001). "Shattuck lecture--neurodegenerative diseases and prions". N Engl J Med. 344 (20): 1516–26. PMID 11357156.
  • Weissmann C (2004). "The state of the prion". Nat Rev Microbiol. 2 (11): 861–71. PMID 15494743.

External Links

cs:Transmisivní spongiformní encefalopatie da:TSE de:Transmissible spongiforme Enzephalopathie ko:프리온 질병 simple:Prion disease



Linked-in.jpg